🚀 VC round data is live in beta, check it out!
Cambridge Cognition Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cambridge Cognition and similar public comparables like Impedimed, AnteoTech, Medclair, CurveBeam AI and more.
Cambridge Cognition Overview
About Cambridge Cognition
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the precise measurement of clinical outcomes in neurological disorders. Geographically, it derives majority of its revenue from the United States of America and also has a presence in the United Kingdom, European Union, and Rest of world. The company services include Neuroscience consultancy, Technical consultancy, Study design, Data analysis, Study management, Data management, and Reports and interpretation.
Founded
2012
HQ
Employees
84
Website
Financials (LTM)
EV
$23M
Cambridge Cognition Financials
Cambridge Cognition reported last 12-month revenue of $14M and negative EBITDA of ($18K).
In the same LTM period, Cambridge Cognition generated $11M in gross profit, ($18K) in EBITDA losses, and had net loss of ($2M).
Revenue (LTM)
Cambridge Cognition P&L
In the most recent fiscal year, Cambridge Cognition reported revenue of $13M and EBITDA of ($673K).
Cambridge Cognition expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $14M | XXX | $13M | XXX | XXX | XXX |
| Gross Profit | $11M | XXX | $9M | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 75% | XXX | XXX | XXX |
| EBITDA | ($18K) | XXX | ($673K) | XXX | XXX | XXX |
| EBITDA Margin | (0%) | XXX | (5%) | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | (4%) | XXX | XXX | XXX |
| Net Profit | ($2M) | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | (11%) | XXX | (18%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cambridge Cognition Stock Performance
Cambridge Cognition has current market cap of $23M, and enterprise value of $23M.
Market Cap Evolution
Cambridge Cognition's stock price is $0.49.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $23M | $23M | 0.0% | XXX | XXX | XXX | $-0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCambridge Cognition Valuation Multiples
Cambridge Cognition trades at 1.6x EV/Revenue multiple, and (1244.4x) EV/EBITDA.
EV / Revenue (LTM)
Cambridge Cognition Financial Valuation Multiples
As of April 20, 2026, Cambridge Cognition has market cap of $23M and EV of $23M.
Equity research analysts estimate Cambridge Cognition's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cambridge Cognition has a P/E ratio of (15.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $23M | XXX | $23M | XXX | XXX | XXX |
| EV (current) | $23M | XXX | $23M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | (1244.4x) | XXX | (33.6x) | XXX | XXX | XXX |
| EV/EBIT | 189.0x | XXX | (49.3x) | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | 2.4x | XXX | XXX | XXX |
| P/E | (15.1x) | XXX | (10.2x) | XXX | XXX | XXX |
| EV/FCF | (21.3x) | XXX | 253.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cambridge Cognition Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cambridge Cognition Margins & Growth Rates
Cambridge Cognition's revenue in the last 12 month grew by 34%.
Cambridge Cognition's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Cambridge Cognition's rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cambridge Cognition's rule of X is 83% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Cambridge Cognition Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 34% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Margin | (0%) | XXX | (5%) | XXX | XXX | XXX |
| EBITDA Growth | (15074%) | XXX | (326%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 39% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 83% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 27% | XXX | 30% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 34% | XXX | 35% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 24% | XXX | 26% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 88% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cambridge Cognition Public Comps
See public comps and valuation multiples for other Healthcare Software and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cambridge Cognition | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| AnteoTech | XXX | XXX | XXX | XXX | XXX | XXX |
| Medclair | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| NanoRepro | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cambridge Cognition M&A Activity
Cambridge Cognition acquired XXX companies to date.
Last acquisition by Cambridge Cognition was on XXXXXXXX, XXXXX. Cambridge Cognition acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cambridge Cognition
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCambridge Cognition Investment Activity
Cambridge Cognition invested in XXX companies to date.
Cambridge Cognition made its latest investment on XXXXXXXX, XXXXX. Cambridge Cognition invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cambridge Cognition
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cambridge Cognition
| When was Cambridge Cognition founded? | Cambridge Cognition was founded in 2012. |
| Where is Cambridge Cognition headquartered? | Cambridge Cognition is headquartered in United Kingdom. |
| How many employees does Cambridge Cognition have? | As of today, Cambridge Cognition has over 84 employees. |
| Is Cambridge Cognition publicly listed? | Yes, Cambridge Cognition is a public company listed on London Stock Exchange. |
| What is the stock symbol of Cambridge Cognition? | Cambridge Cognition trades under COG ticker. |
| When did Cambridge Cognition go public? | Cambridge Cognition went public in 2013. |
| Who are competitors of Cambridge Cognition? | Cambridge Cognition main competitors are Impedimed, AnteoTech, Medclair, CurveBeam AI. |
| What is the current market cap of Cambridge Cognition? | Cambridge Cognition's current market cap is $23M. |
| What is the current revenue of Cambridge Cognition? | Cambridge Cognition's last 12 months revenue is $14M. |
| What is the current revenue growth of Cambridge Cognition? | Cambridge Cognition revenue growth (NTM/LTM) is 34%. |
| What is the current EV/Revenue multiple of Cambridge Cognition? | Current revenue multiple of Cambridge Cognition is 1.6x. |
| Is Cambridge Cognition profitable? | No, Cambridge Cognition is not profitable. |
| What is the current EBITDA of Cambridge Cognition? | Cambridge Cognition has negative EBITDA and is not profitable. |
| What is Cambridge Cognition's EBITDA margin? | Cambridge Cognition's last 12 months EBITDA margin is (0%). |
| What is the current EV/EBITDA multiple of Cambridge Cognition? | Current EBITDA multiple of Cambridge Cognition is (1244.4x). |
| What is the current FCF of Cambridge Cognition? | Cambridge Cognition's last 12 months FCF is ($1M). |
| What is Cambridge Cognition's FCF margin? | Cambridge Cognition's last 12 months FCF margin is (8%). |
| What is the current EV/FCF multiple of Cambridge Cognition? | Current FCF multiple of Cambridge Cognition is (21.3x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.